Rodyti straipsnį

Onkologija (vaikai)

Klinikinės baigtys

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children's Oncology Group trial AAML0531. (atsiveria naujas langas)

Gamis AS, Alonzo TA, Meshinchi S, Sung L, Gerbing RB, Raimondi SC, Hirsch BA, Kahwash SB, Heerema-McKenney A, Winter L, Glick K, Davies SM, Byron P, Smith FO, Aplenc R

Šaltinis‎: J Clin Oncol 2014;32(27):3021-32.

Kodas‎: PubMed 25092781

DOI‎: 10.1200/JCO.2014.55.3628

https://www.ncbi.nlm.nih.gov/pubmed/25092781 (atsiveria naujas langas)

Red blood cell transfusion and outcome in cancer. (atsiveria naujas langas)

Iqbal N, Haider K, Sundaram V, Radosevic J, Burnouf T, Seghatchian J, Goubran H

Šaltinis‎: Transfus Apher Sci 2017;56(3):287-90.

Kodas‎: PubMed 28602484

DOI‎: 10.1016/j.transci.2017.05.014

https://www.ncbi.nlm.nih.gov/pubmed/28602484 (atsiveria naujas langas)

Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases. (atsiveria naujas langas)

Oh SY, Kim SH, Kwon HC, Lee S, Kim KH, Kwon KA, Lee JH, Lee KY, Kim HJ

Šaltinis‎: Support Care Cancer 2010;18(10):1341-6.

Kodas‎: PubMed 19841950

DOI‎: 10.1007/s00520-009-0759-3

https://www.ncbi.nlm.nih.gov/pubmed/19841950 (atsiveria naujas langas)